Dr Nikolai Petrovsky | Chairman
Vaxine Pty.

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Nikolai Petrovsky is Professor of Medicine at Flinders University and founder of Vaxine Pty Ltd.  Known internationally for his vaccine adjuvant research he has held several large Adjuvant Development contracts from the U.S. National Institutes of Health. His research has won many awards including the 2010 Ernst & Young Entrepreneur of the Year Award, 2011 BioSpectrum Asia-Pacific Emerging Company of the Year Award, a 2011 Vaccine Industry Excellence Award for Most Innovative Asian Biotech and 2013 Biopharma Asia, Asian Executive of the Year Award. He has taken multiple vaccines, including for influenza, hepatitis B and allergy from the bench to the clinic and has authored over 100 research papers.


Day 1 Oct 10th Immune Profiling @ 11:45

Why haven't Alzheimer's vaccines succeeded yet?

  • Abeta and tau still valid AD targets
  • Past AD vaccines were very poorly immunogenic, explaining lack of efficacy
  • Structured AD vaccine design ensures maximal immune recognition
  • Good adjuvants are essential for effective AD vaccines

back to speakers